Financials
Financial year 2026
JUBILANT LIFE SCIENCES from Merelbeke-Melle, company number BE0536745342, closed financial year 2026 with a result of € 2 million after tax. For that financial year JUBILANT LIFE SCIENCES recorded revenue of € 46.6 million and equity of € 8.9 million. Compared with financial year 2025, the result moved from € 1.3 million to € 2 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ 8.9 million
▲ 29% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2 million
▲ 52% vs 2025
Profit after tax over the fiscal year.
€ 871,990
▼ 47% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 8.8 million.
People and assets in 2026
2
Average over the fiscal year, from the social balance sheet.
€ 803,120
▲ 111% vs 2025
€ 401,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 12,472
▼ 20% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 3,651
Loans from banks and other lenders, long and short.
€ 6 million
▼ 32% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 51 days on average.
€ 39,765
▼ 64% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 81,315,319 | € 67,168,240 | € 63,909,407 | € 46,568,375 | ▼ 27% |
| Profit after taxes | € 281,655 | € 211,434 | € 1,329,652 | € 2,016,562 | ▲ 52% |
| Equity | € 5,335,356 | € 5,546,790 | € 6,876,442 | € 8,893,004 | ▲ 29% |
| Total debts | € 28,355,161 | € 33,570,966 | € 26,876,127 | € 15,490,023 | ▼ 42% |
| Cash | € 1,764,574 | € 988,114 | € 1,632,472 | € 871,990 | ▼ 47% |
| Retained profit | € 5,235,356 | € 5,446,790 | € 6,776,442 | € 8,793,004 | ▲ 30% |
| Bank debt | € 0 | € 0 | € 0 | € 3,651 | |
| Balance sheet total | € 33,690,517 | € 39,117,755 | € 33,752,568 | € 24,383,026 | ▼ 28% |
| Employees (FTE) | 1.5 | 2.1 | 2 | 2 |
Key figures of JUBILANT LIFE SCIENCES, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to JUBILANT LIFE SCIENCES?
What happened at JUBILANT LIFE SCIENCES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 2 million (▲ 52% vs 2025). Source: NBB ↗
- Chandrodey Pandey became a director. NBB
- Amit Kumar Mishra became a director. NBB
- Rishi Gangwar stepped down as director. NBB
- Vinay Sharma stepped down as director. NBB
- Rajesh Bhatia became a director. NBB
- New establishment in Merelbeke-Melle. KBO
- Start of the company according to the CBE. KBO
In short
From € 281,655 profit in 2023 to € 2 million profit in 2026.
Paid € 1.3 million in corporate taxes since 2023.
Best year ever: 2026, with € 2 million profit.
Pays suppliers within 51 days on average.
A new publication or filing at JUBILANT LIFE SCIENCES? We notify you, reason included.
Follow JUBILANT LIFE SCIENCESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind JUBILANT LIFE SCIENCES are Rajesh Bhatia, Chandrodey Pandey and Amit Kumar Mishra.
Directors
According to the 2026 annual accounts
Rajesh Bhatia
Director
since 2022
Chandrodey Pandey
Director
since 2026
Amit Kumar Mishra
Director
since 2026
Rishi Gangwar
Director
· until 2026
Vinay Sharma
Director
· until 2026
Establishments
Establishment units
Physical locations of this company
Guldensporenpark 22
9820 Merelbeke-Melle
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0536.745.342
- VAT number
- BE 0536.745.342
- Registered office
- Guldensporenpark 22, 9820 Merelbeke-Melle
- Names & denominations
- JUBILANT LIFE SCIENCES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 July 2013
- Peppol
- Active · Active since 19 Nov 2025
- Activities · NACE
Groothandel in chemische producten voor industrieel gebruik